ClinicalTrials.Veeva

Menu

PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor

N

Northern California Institute of Research and Education (NCIRE)

Status

Terminated

Conditions

Mhealth
Hypertension
Blood Pressure

Treatments

Device: PACESETTER

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03401489
5R01MD012441-05 (U.S. NIH Grant/Contract)
Pro00070627

Details and patient eligibility

About

Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor (PACESETTER) aims to assess the incorporation of its stroke intervention into 2 safety net/academic health systems in a given US state especially burdened by stroke, thereby enhancing knowledge about the complexity of stroke interventions, and especially the nature of the challenges encountered in low resource settings and for populations traditionally underrepresented in research. Altogether, the intervention, if proven implementable and effective, may eventually be exported to other medically underserved populations in the US beyond SC as a feasible model of post-stroke management.

Enrollment

120 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • African American or non-Hispanic white
  • history of stroke (within six months of symptom onset)
  • uncontrolled HTN (SBP ≥ 130 mmHg at the last clinical encounter post-stroke prior to recruitment)
  • owning a smartphone with a data plan
  • able to take their own BP and self-administer medications.

Exclusion criteria

  • Any condition that would limit participation in follow up assessments including severe cognitive impairment/dementia

    • severe global disability (modified Rankin Score ≥ 3)
    • BMI> 40kg/m^2
    • Not being able to speak, hear, or understand English

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups

PACESETTER
Experimental group
Description:
Participants in the PACESETTER arm received a multicomponent, mHealth-enabled self-management program designed to improve post-stroke blood-pressure control. Each participant was provided a Bluetooth-enabled UA-767Plus BT home blood-pressure monitor, a Vaica electronic medication tray that emitted visual and auditory reminders, and the PACESETTER smartphone app. The app delivered instructional videos, enabled automatic transmission of BP and adherence data to a secure server, and generated tailored SMS messages based on self-determination-theory constructs of competence and autonomous regulation. Participants also received twice-weekly educational text messages regarding hypertension and stroke prevention, medication adherence, and communication with clinicians. Bi-weekly adherence and BP summaries were sent to study physicians to guide medication adjustments. Study coordinators contacted participants monthly to ensure device functioning and collect follow-up data.
Treatment:
Device: PACESETTER
Healthy Lifestyle Intervention Group
No Intervention group
Description:
General lifestyle SMS matched in frequency and length to the intervention; monthly follow-ups; no devices, adherence monitoring, or physician-directed feedback.

Trial documents
1

Trial contacts and locations

4

Loading...

Central trial contact

Raelle Tagge, MPH; Bruce Ovbiagele, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems